Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's p... Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others. Mostrar mais
Pergunte à ADVFN Intelligence (IA)
| Período | Var | Var % | Abe | Máx. | Mín. | Vol Méd. | VWAP diário | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.1 | -13.0641330166 | 8.42 | 8.8 | 6.76 | 42804 | 7.81461716 | CS |
| 4 | -6.85 | -48.3415666902 | 14.17 | 16.24 | 6.76 | 105784 | 10.06958919 | CS |
| 12 | -5.7425 | -43.961722488 | 13.0625 | 19.5 | 6.76 | 203082 | 12.53219654 | CS |
| 26 | -18.43 | -71.572815534 | 25.75 | 27.5 | 6.76 | 301142 | 13.46964175 | CS |
| 52 | -11.93 | -61.974025974 | 19.25 | 30 | 6.76 | 314728 | 16.52389741 | CS |
| 156 | -337.18 | -97.8751814224 | 344.5 | 449.25 | 6.76 | 268084 | 50.80237143 | CS |
| 260 | -361.18 | -98.013568521 | 368.5 | 937.7475 | 6.76 | 245816 | 131.71800172 | CS |
Suporte: (11) 4950 5808 | suporte@advfn.com.br
Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições
Recursos principais
Premium
